Bank of Montreal’s iBio IBIO Stock Holding History

Bank of Montreal’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-17	Closed	-$13K	–	4233
2021 Q1	$13K	Sell	17 -43	-72%	-$37.5K	﹤0.01%	4233
2020 Q4	$38K	Buy	60 +50	+500%	+$40.7K	﹤0.01%	4084
2020 Q3	$9K	Buy	10 +2	+25%	+$2.9K	﹤0.01%	4173
2020 Q2	$9K	Buy	+8	New	+$5.23K	﹤0.01%	4215

Other funds holding IBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Bank of Montreal's IBIO Position: Q2 2021 in Review

Bank of Montreal sold out of iBio (IBIO) in Q2 2021, closing a stake of 17 shares — an estimated $13K sold.

Bank of Montreal first reported a position in IBIO in Q2 2020 and held it in 4 quarters. The position peaked at $38K in Q4 2020. 83 funds tracked by Wall St. Rank hold IBIO as of Q2 2021.

Bank of Montreal reported no remaining iBio position as of Q2 2021 after selling out during the quarter.
Bank of Montreal sold 17 iBio shares in Q2 2021, an estimated $13K.
Bank of Montreal first reported a position in iBio in Q2 2020 and held it in 4 quarters.
Bank of Montreal's iBio position peaked at $38K in Q4 2020.
83 funds tracked by Wall St. Rank held iBio as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.